CompletedNCT00435370
Tropisetron added to risperidone for cognitive and perceptual difficulties in schizophrenia
About this title
Read the official source — NCT00435370Medication studyAges 18–64United States + China
Understand this study
Who was this study for?
Listed age limits: 18 years to 64 years.
- Listed locations
- Houston and 1 more locationSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateNovember 2006
- Recruitment status
- Completed
- Enrollment listed in the registry
- 179
- Sponsor
- Baylor College of Medicine
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States, China
- Age range
- From 18 Years to 64 Years
- Official registry ID
- NCT00435370
- Official title
Show the full official title
Tropisetron With Risperidone for Schizophrenia
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Houston, United States · Beijing, China
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Baylor College of Medicine, a university.
Did this study involve medication?
Yes. The study involved medication, including Tropisetron, Placebo and Risperidone.
Who was this study for?
Listed age limits: 18 years to 64 years.
